RxSight (NASDAQ:RXST) Upgraded to "Overweight" at Wells Fargo & Company
Wells Fargo & Company upgraded shares of RxSight (NASDAQ:RXST – Free Report) from an equal weight rating to an overweight rating in a research report report published on Wednesday morning, Marketbeat Ratings reports. They currently have $42.00 target price on the stock, up from their prior target price of $31.00. A number of other equities […]